SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by GAMMA Investing LLC

GAMMA Investing LLC decreased its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 69.6% in the fourth quarter, HoldingsChannel.com reports. The firm owned 332 shares of the exchange traded fund’s stock after selling 759 shares during the quarter. GAMMA Investing LLC’s holdings in SPDR S&P Biotech ETF were worth $30,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. Synovus Financial Corp boosted its stake in shares of SPDR S&P Biotech ETF by 110.9% in the third quarter. Synovus Financial Corp now owns 9,391 shares of the exchange traded fund’s stock worth $928,000 after acquiring an additional 4,939 shares during the last quarter. Sanctuary Advisors LLC raised its stake in SPDR S&P Biotech ETF by 12.7% in the 3rd quarter. Sanctuary Advisors LLC now owns 15,166 shares of the exchange traded fund’s stock valued at $1,460,000 after purchasing an additional 1,711 shares during the last quarter. Pine Valley Investments Ltd Liability Co lifted its holdings in SPDR S&P Biotech ETF by 33.0% in the 3rd quarter. Pine Valley Investments Ltd Liability Co now owns 10,387 shares of the exchange traded fund’s stock valued at $1,026,000 after purchasing an additional 2,577 shares in the last quarter. Westside Investment Management Inc. boosted its stake in SPDR S&P Biotech ETF by 3.4% during the 3rd quarter. Westside Investment Management Inc. now owns 6,170 shares of the exchange traded fund’s stock worth $610,000 after purchasing an additional 200 shares during the last quarter. Finally, Invst LLC grew its holdings in shares of SPDR S&P Biotech ETF by 6.0% during the third quarter. Invst LLC now owns 2,807 shares of the exchange traded fund’s stock worth $277,000 after buying an additional 160 shares in the last quarter.

SPDR S&P Biotech ETF Trading Down 2.8 %

XBI stock opened at $86.66 on Wednesday. The firm has a 50-day moving average of $95.28 and a two-hundred day moving average of $97.10. SPDR S&P Biotech ETF has a 12 month low of $81.14 and a 12 month high of $105.47. The company has a market cap of $6.61 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.